Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Lung adenocarcinoma with neuroendocrine differentiation: Molecular markers testing and treatment outcomes.

Journal of the Formosan Medical Association = Taiwan yi zhi - 1 Aug 2023

Chang Hao-Chun, Chen Kuan-Yu, Chang Yih-Leong, Shih Jin-Yuan, Yu Chong-Jen

Abstract excerpt

BACKGROUND: Among the histologic types of lung cancer, adenocarcinoma is the most common. Moreover, lung adenocarcinoma with neuroendocrine differentiation (LANED) is a rare histologic character. So far, the clinical significance remains unclear. MATERIAL AND METHODS: We searched for the patients diagnosed with LANED from the electronic pathology database between January 2000 and June 2020 in a tertiary hospital....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Adenocarcinoma of Lung

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to B7-H1 Antigen

Share to Biomarkers

Share to Lung Neoplasms

Share to Receptor Protein-Tyrosine Kinases

Share to Treatment Outcome

Source

Identifiers

PMID: 36586785
DOI: 10.1016/j.jfma.2022.12.011

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Lung adenocarcinoma with neuroendocrine differentiation: Molecular markers testing and treatment outcomes.PMID 36586785Read ↗

Molecular Pathology of Pulmonary Large Cell Neuroendocrine Carcinoma: Novel Concepts and TreatmentsSemantic proximity Read ↗

The Unmet Diagnostic and Treatment Needs in Large Cell Neuroendocrine Carcinoma of the LungSemantic proximity Read ↗

Beyond Traditional Morphological Characterization of Lung Neuroendocrine Neoplasms: In Silico Study of Next-Generation Sequencing Mutations Analysis across the Four World Health Organization Defined GroupsSemantic proximity Read ↗

Molecular and Morphological Profiling of Lung Cancer: A Foundation for “Next-Generation” Pathologists and OncologistsSemantic proximity Read ↗

Large Cell Neuroendocrine Carcinoma of the Lung: Clinico-Pathologic Features, Treatment, and Outcomes.Semantic proximity Read ↗

p53+/-Rb1-ASCL1low phenotype predicts better prognosis after surgical resection in large cell neuroendocrine carcinoma: a molecular characteristic and clinical-pathological investigation of lung neuroendocrine tumorsSemantic proximity Read ↗

p53+/-Rb1-ASCL1low Phenotype Predicts Better Prognosis After Surgical Resection in Large Cell Neuroendocrine Carcinoma: a Molecular Characteristic and Clinical-pathological Investigation of Lung Neuroendocrine TumorsSemantic proximity Read ↗

P53 +/- Rb1 - ASCL1 low Phenotype Predicts Better Prognosis after Surgical Resection in Large Cell Neuroendocrine Carcinoma: A Molecular Characteristic and Clinical-Pathological Investigation of Lung Neuroendocrine TumorsSemantic proximity Read ↗

Integrated Molecular and Clinical Characterization of Pulmonary Large Cell Neuroendocrine CarcinomaSemantic proximity Read ↗

New molecular classification of large cell neuroendocrine carcinoma and small cell lung carcinoma with potential therapeutic impactsSemantic proximity Read ↗

Mutation profile and programmed death ligand 1 status of patients with non-small cell lung cancer diagnosed with "adenocarcinoma" and "non-small cell carcinoma favor adenocarcinoma".Semantic proximity Read ↗

ASCL1 and RET expression defines a clinically relevant subgroup of lung adenocarcinoma characterized by neuroendocrine differentiationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.